Sobi to buy US Biotech Arthrosi for up to $1.5 B
13 Dec 2025 //
REUTERS
Arthrosi Raises $153M, Fueling Dash Toward Phase 3 Gout Data
08 Oct 2025 //
FIERCE BIOTECH
Arthrosi Completes Ph3 Trial Enrollment for Pozdeutinurad in Gout
20 Aug 2025 //
PR NEWSWIRE

Market Place
Sourcing Support